Metabolic syndrome is described as a multi‐faceted disorder incorporating obesity, impaired fasting glucose and/or impaired glucose tolerance, reduced insulin sensitivity and dyslipidaemia that predisposes type 2 diabetes (T2D) (Alberti et al. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.